ArticleFrontiers in immunology2025

Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemotherapy followed by radiotherapy with maintenance therapy: a case report.

Juan Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.